Cochrane review dismissing amyloid drugs draws immediate backlash
科克伦协作网评论否定淀粉样蛋白药物，旋即引发强烈反弹

A new report trying to settle a decades-old debate about Alzheimer’s disease has reached a dramatic conclusion: Antibody drugs that target sticky amyloid beta proteins in the brain simply don’t work.
一份旨在了结阿尔茨海默病数十年争论的新报告得出惊人结论：靶向大脑黏性β-淀粉样蛋白的抗体药物根本不起作用。